Deerfield Management Company, L.P. (Series C) Biom X Inc. Put Options Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.84 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding PHGE
# of Institutions
11Shares Held
13.8MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA4.52MShares$1.54 Million0.05% of portfolio
-
Johnson & Johnson New Brunswick, NJ1.92MShares$653,8880.18% of portfolio
-
8 Vc Gp I, LLC Austin, TX1.09MShares$369,3040.62% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny80.6KShares$27,4040.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny19.8KShares$6,7190.0% of portfolio
About BiomX Inc.
- Ticker PHGE
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,982,300
- Market Cap $10.2M
- Description
- BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibr...